BIANCHI, MARZIA
 Distribuzione geografica
Continente #
NA - Nord America 8.296
EU - Europa 5.157
AS - Asia 1.579
OC - Oceania 19
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 4
Totale 15.074
Nazione #
US - Stati Uniti d'America 8.253
GB - Regno Unito 2.296
CN - Cina 1.126
UA - Ucraina 820
IT - Italia 624
SE - Svezia 467
FI - Finlandia 319
TR - Turchia 257
DE - Germania 242
IE - Irlanda 185
FR - Francia 55
IN - India 42
CA - Canada 38
KR - Corea 37
RU - Federazione Russa 34
BE - Belgio 33
JP - Giappone 30
VN - Vietnam 24
SG - Singapore 23
PL - Polonia 16
CZ - Repubblica Ceca 15
NL - Olanda 15
AU - Australia 14
PK - Pakistan 14
AT - Austria 10
TG - Togo 8
RO - Romania 7
IR - Iran 6
EU - Europa 5
NZ - Nuova Zelanda 5
ES - Italia 4
HK - Hong Kong 4
TW - Taiwan 4
ZA - Sudafrica 4
HU - Ungheria 3
MX - Messico 3
CH - Svizzera 2
CL - Cile 2
IL - Israele 2
KZ - Kazakistan 2
MY - Malesia 2
PT - Portogallo 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
GR - Grecia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.074
Città #
Southend 2.147
Woodbridge 1.177
Fairfield 1.141
Ashburn 782
Houston 737
Ann Arbor 736
Jacksonville 659
Chandler 510
Seattle 484
Cambridge 455
Wilmington 391
Nanjing 324
Izmir 247
Dublin 183
Helsinki 138
Nanchang 129
Urbino 126
Beijing 112
Princeton 97
San Mateo 94
Boardman 93
Shenyang 82
Hebei 65
Changsha 61
Düsseldorf 60
New York 57
Tianjin 52
Bremen 50
Jiaxing 45
San Diego 39
Jinan 35
Brussels 32
Kunming 31
Mülheim 31
Seongnam 26
Velikiy Novgorod 26
Hangzhou 25
San Francisco 25
Zhengzhou 25
Dong Ket 24
London 20
Ningbo 20
Ottawa 20
Shanghai 15
Venice 15
Brno 14
Des Moines 14
Rawalpindi 14
Toronto 14
Redwood City 13
Agugliano 12
Kraków 12
Lanzhou 12
Munich 12
Norwalk 12
Ascoli Piceno 11
Changchun 11
Wuppertal 11
Pesaro 10
Taizhou 10
Guangzhou 9
Los Angeles 9
Auburn Hills 8
Lomé 8
Singapore 8
Vienna 8
Vittuone 8
Alexandria 7
Ancona 7
Copparo 7
Falls Church 7
Haikou 7
Seoul 7
Tokyo 7
Caserta 6
Macerata 6
Osimo 6
Portland 6
Amsterdam 5
Bologna 5
Fano 5
Mergo 5
Paris 5
Sydney 5
Castorano 4
Civitanova Marche 4
Cosenza 4
Frankfurt am Main 4
Iesi 4
Lariano 4
Las Vegas 4
Melbourne 4
Montemarciano 4
Mumbai 4
Napoli 4
Rimini 4
Rome 4
Torre Del Greco 4
Turin 4
Acqualagna 3
Totale 12.049
Nome #
Yin Yang 1 intronic binding sequences and splicing elicit intron-mediated enhancement of ubiquitin C gene expression 387
Stochastic modelling of PTEN regulation in brain tumors: a model for Glioblastoma Multiforme 342
Covalent functionalization of SWCNTs with ODNs targeting NF-kB: toward the construction of cell-penetrating decoy molecoles. 317
Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions 280
Ubiquitin C gene: Structure, function, and transcriptional regulation 265
Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells 259
Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone 246
Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants 239
Label-free quantification of activated NF-kB in biological samples by atomic force microscopy 229
A potent enhancer element in the 5'-UTR intron is crucial for transcriptionalregulation of the human ubiquitin C gene 223
Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells 218
Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity 215
Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity. 212
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 203
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 199
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 196
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 195
Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes 192
Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity 191
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 191
Expression, purification, and characterization of a recombinant erythroid-specific hexokinase isozyme 189
De-ubiquitylation is the most critical step in the ubiquitin mediated homeostatic control of the NF-kB/IKK basal activity 184
Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules 184
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 184
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation 177
Dehydroascorbic acid irreversibly inhibits hexokinase activity. 176
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. 176
Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin 172
A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription. 171
Design and characterization of decoy oligonucleotides containing locked nucleic acids 169
Structural determinants that make hexokinase susceptible to ubiquitin- and ATP-dependent proteolysis 168
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 164
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 164
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 163
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 162
Drug delivery systems 162
Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control. 162
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 161
Red Blood Cell Membrane Processing for Biomedical Applications 160
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 159
Genomic DNA in human blastocoele fluid 158
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB) 157
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 157
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 156
Molecular bases of hexokinase deficiency 155
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 154
High-level expression and purification of a human "mini"-hexokinase 154
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 152
DOWNREGULATION OF NITRIC OXIDE FORMATION BY CYTOSOLIC PHOSPHOLIPASE A2-RELEASED ARACHIDONIC ACID. 152
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 148
Hexokinase mutations that produce nonspherocytic hemolytic anemia 148
Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines 145
Improved metabolic properties of hexokinase-overloaded human erythrocytes 142
Hexokinase 142
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 141
Expression of hexokinase mRNA in human hippocampus 138
Monitoring erythropoietin abuse in athletes 138
Modulation of NF-kB activation by targeted delivery of dexamethasone to macrophages 137
Overexpression of wild-type ubiquitin downregulates transcription of endogenous polyubiquitin genes in HeLa cells 135
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 135
Ubiquitin overexpression leads to stabilization of p53 and increased p21 (CIP1/WAF1) transcription by promoting E6AP autodegradation in HeLa cells 133
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 132
LOCKED NUCLEIC ACIDS (LNA): VERSATILE TOOLS FOR DESIGNING OLIGONUCLEOTIDE DECOYS WITH HIGH STABILITY AND AFFINITY 132
Expression, purification and preliminary crystallographic studies of human hexokinase I 130
The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells 130
Drug-loaded red blood cells for the control of the inflammatory response: selective targeting of nuclear factor-kB (NF-kB) 129
Human hexokinase type I microheterogeneity is due to different amino-terminal 129
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 128
Ubiquitin over-expression promotes E6AP degradation and reactivation of the p53/mdm-2 pathway 128
Localization and age-dependent expression of hexokinase mRNA in the rat brain 125
Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkB-alpha turnover 120
Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies 117
Extraction and reversed-phase high-performance liquid chromatographic determination of 2',3'-dideoxycytidine from human blood samples. 116
Ubiquitin-dependent regulation of E6AP protein levels 114
Enzymatic properties of overexpressed human hexokinase fragments 106
Induction of ubiquitin C (UBC) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress 106
Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes 103
MOLECULAR BASES OF NONSPHEROCYTIC HEMOLYTIC ANEMIA DUE TO HEXOKINASE MUTATIONS 100
Different intron-mediated enhancement mechanisms for the 5'-UTR intron of the human UbC gene 100
Role of heat shock transcription factors in the induction of UbC gene expression in MG132-treated cells 98
Efficient inhibition of macrophage TNF-alpha production by red cell mediated drug targeting 98
UbC trascription is modulated by a mechanism that senses ubiquitin pool dynamics. 98
Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone 97
Modulation of macrophage activation by red cell-mediated drug targeting 96
Overexpression of ubiquitin downregulates transcription of the endogenous UbC gene in HeLa cells 94
FKBP12-loaded erythrocytes as a potential delivery system for the immunosuppressant Tacrolimus 91
INCREASED GLUCOSE CONSUMPTION BY HUMAN AND MICE ERYTHROCYTES OVERLOADED WITH HEXOKINASE AND GLUCOSE OXIDASE. 89
Molecular mechanism involved in glucocorticoid analogue action in Ataxia Telangiectasia: diferrentially expressed genes in AT cell lines in response to Dexamethasone 88
Design of decoys oligonucleotides stabilized by Locked Nucleic Acids. 86
Engineered Red Blood Cells for the delivery and targeting of corticosteroid analogues 83
Extraction and reversed-phase high-performance liquid chromatographic determinaton of 2',3'-dideoxycytidine from human blood samples. 82
Transgene-derived wild-type and mutant ubiquitin affects both proteolysis and transcription in HeLa cells. 78
null 76
Increased glucose metabolism by enzyme-loaded erythrocytes in vitro and in vivo normalization of hyperglycemia in diabetic mice 65
Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine. 64
A new humanized antibody is effective against pathogenic fungi in vitro 60
null 57
Modulation of ICAM-1 expression in ECV304 cells by macrophage conditioned medium 51
Dynamic changes in immunoproteasome assembly and capping with regulatory particles in an invitro model of senescing macrophages 42
Development and in vitro characterization of a humanized scFv against fungal infections 36
Totale 15.057
Categoria #
all - tutte 43.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.482 609 148 257 790 150 251 295 251 187 241 164 139
2020/20212.125 92 218 215 217 141 170 147 129 294 164 230 108
2021/20221.089 80 97 119 152 36 44 49 60 91 71 29 261
2022/20231.703 199 90 28 181 165 344 1 156 313 72 98 56
2023/2024817 51 44 16 78 26 118 22 298 8 69 7 80
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 15.227